Erectile Dysfunction News Archive
Alert patients that use of performance-enhancing drugs can lead to erectile dysfunction and infertility.
The chances of erectile function recovery improved when patients received radiation treatment more than 16 months after surgery.
Potency is preserved in 50.4% and 60.8% of patients at 10 years after seed implantation, according to MSSFI and SHIM scores, respectively.
An early, integrated approach led to less deterioration of erectile function after surgery.
Almost quadruple the risk found among Asian men with erectile dysfunction.
Review finds 1.5-3.4 times higher risk of erectile dysfunction among men with periodontitis.
Men undergoing surgery should inform their anesthesiologist about any use of erectile dysfunction drugs.
Many men are unaware of erectile function recovery time and problems with ejaculation.
A combination of exercise and a flavonoid-rich diet can reduce the risk of erectile dysfunction by 21%.
Non-users of 5-alpha-reductase inhibitors had a nearly 2.6 times increased risk of pathologic progression than those who took the drugs.
No significant association found between phosphodiesterase type 5 inhibitor use and biochemical recurrence after radical treatment.
In a small study, 79% of men reported satisfaction with penile prosthesis implantation surgery, supporting its use as an erectile dysfunction treatment.
Small study shows those undergoing radiation therapy had fewer side effects, less fatigue.
Researchers investigate sexual dysfunction post RT for localized prostate cancer.
In a study, mean aldosterone levels increased with severity of ED.
Urology subspeciality andrologists perform disproportionately higher numbers of procedures.
After 2 years, continence, potency, and freedom from recurrence were achieved in almost half of men who had extended pelvic lymph node dissection.
Analytic sample of 692 men wearing ActiGraph 7164 accelerometer confirms inverse association.
It remains important to assess the efficacy and safety of acupuncture for ED.
CAM associated with polypharmacy, vision impairment, and urologic comorbidities.
Lack of association found in a study of men in the placebo arm of the Prostate Cancer Prevention Trial.
Compared with laparoscopic radical prostatectomy, robotic-assisted laparoscopic prostatectomy is associated with a 51% increased likelihood of return of erectile function.
Results of a prospective study have implications for patient counseling.
Men with ED had more than twice the odds of undiagnosed diabetes.
Gout is associated with an elevated likelihood of both organic and psychogenic ED.
Amphetamine users were twice as likely as non-users to experience erectile dysfunction.
Researchers saw no improvement for patients with low testosterone and delayed ejaculation.
Slightly higher odds for men on ED drugs, but lifestyle factors are the likelier culprit.
International effort takes aim at more than 1,050 websites
Gout increased the risk of erectile dysfunction in men by 21%.
Researchers identify depression as the most important determinant.
Study suggests caffeine may help maintain healthy blood flow and sexual function.
Increased odds of erectile dysfunction and/or lower urinary tract symptoms in men with T1DM.
Hypogonadism was present in 42.8% of subjects, yet TRT was used by only 3.9%.
Insertion of these devices decreased from 4.6% of erectile dysfunction cases in 2002 to 2.3% in 2010.
A new report combines data from 20 studies to provide definitive information.
Lower levels have no significant effect; findings consistent in racially diverse population.
High levels of free and bioavailable testosterone are associated with a significantly decreased risk of ED in younger men.
It is cost-effective, potentially saving $21.3 billion over 20 years by preventing 1.1 million cardiovascular events, researchers say.
Men who get the most physical activity report more erections and orgasms.
Lower testosterone levels linked to decreased sexual activity and desire, but not to fewer erections.
Only 6.7% of men reported erections that were as good after radical prostatectomy, as before—much lower than would be expected by IIEF-5 scores.
In this study, over half the men referred for borderline testosterone levels had depression.
Depression is prevalent among men with benign prostatic hyperplasia (BPH).
The authors recommend consideration of testosterone assays in men who fail to respond to PDE5 inhibitors in an effort to optimize outcomes.
Correlation identified between functional capacity and erectile function improvement
Sexual function declines for both men and women following radical prostatectomy, but some aspects of care may help couples.
Men who take phosphodiesterase type 5 inhibitors after radical prostatectomy are more likely to experience biochemical recurrence of disease.
A Turkish study found that 55% of male coronary artery disease patients had some degree of erectile dysfunction.
Potency was observed in 51% of unilateral surgery patients and 71% of bilateral surgery patients who received oral therapy.
Nerve-sparing surgery by robot-assisted laparoscopy was associated with a 2.4 times increased odds of regaining potency versus open surgery
In a placebo-controlled study, 57% of men unable to have intercourse were able to do so without medication after receiving the treatment.
Men with asymptomatic vascular disease are more likely to develop erectile dysfunction (ED) compared to those who don't.
Significantly lower vitamin D level in patients with severe/complete versus mild erectile dysfunction (ED).
Sildenafil (Viagra) has demonstrated improvement in heart function without any adverse effect on blood pressure.
Men with diabetic peripheral neuropathy have an increased occurrence of erectile dysfunction and lower-urinary-tract symptoms.
When it comes to erectile dysfunction (ED) in middle-aged men, testosterone may not be a key factor.
FDA has approved a supplemental new drug application for Stendra (avanafil) taken early as ~15 minutes before sexual activity.
In a study, none of the 62 men who had the treatment experienced erectile dysfunction or urinary incontinence.
Of 6.2 million men diagnosed with the condition, only 25.4% of them filled a prescription for a medical treatment.
At 5 years after seed implantation, 59% prostate cancer patients had preserved erectile function.
Obesity can lead to a deterioration of erectile function in young men.
Experts note study findings aren't definitive, and risk is minimal.
Researchers compared with low-intensity shockwave therapy with sham treatment.
Many patients who fail with PDE5is are using the medications improperly.
Single-institution study finds most patients satisfied with the results and would have the surgery again.
Allowing 1, 2, or 3 or more days between the first and second injection of collagenase clostridium histolyticum does not impact efficacy.
Perceived outcomes of patients aged 29 years or younger are different from those of patients in other age groups, study finds.
Study reveals no significant impact on changes in penile curvature or length.
IIEF scores at 6 months post-op not significantly different from baseline, study finds.
A significant proportion of these men have vascular abnormalities, a study found.
Researchers observe a short-term significant decline erectile function at 1 month, but this fully recovers by 6 months.
Loss of penile sensation after plaque incision and grafting surgery for Peyonie's disease declines over time.
In a study of rats, penile traction had the edge for correcting curvature, but a vacuum erectile device was better for preserving erectile function.
Intake of 85-303 mg/day has an apparent protective effect, researchers found.
Study also shows a 6-fold higher rate of hypogonadism compared with the general population.
Study compared surgeons who switched from open procedures to MIRP with those who used MIRP exclusively.
Erectile dysfunction of some degree was present in 54% of those presenting for urethroplasty.
Penile traction therapy reduced curvature and significantly improved erectile function and hardness.
Range of risk factors identified for incidence and remission of ED, dyadic and solitary sexual desire.
Drug no better than placebo in preventing erectile dysfunction after radiotherapy for prostate cancer.
Men with high cholesterol and ED who used the drugs experienced a significant 3.2-point increase in IIEF score versus controls.
In a study of patients undergoing coronary procedures, the incidence of CIN was 2.7% alprostadl recipients versus 11.1% of controls.
Systematic review and meta-analysis show that use of the lipid-lowering agents can improve erectile function scores.
In a trial, more patients taking sildenfail citrate than placebo daily had functional erections at 24 months.
Complications other than urinary incontinence or erectile dysfunction occur frequently following treatment for PCa.
In men aged 44 years or less, total testosterone levels drop off significantly after 9 AM, study shows.
Patients with coronary artery disease are more likely to have ED if they have elevated uric acid levels.
If it lasts more than 48 hours, the T-shunt procedure with intracavernous tunneling usually fails, leaving men with erectile dysfunction.
As fasting plasma glucose levels and HbA1c values increased, so did the odds of ED.
ED sufferers with diabetes are 55% more likely be prescribed second-line therapies than non-diabetics, data show.
It is the first medication approved by the agency for treating this erectile problem.
The drug combination was associated with significantly improved erectile function and partner satisfaction in men who did not respond to testosterone alone.
ED and neovascular age-related macular degeneration share some similar risk factors.
Men with irritable bowel syndrome (IBS) are at higher risk of erectile dysfunction (ED) than men without IBS.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)